» Articles » PMID: 9034752

Coronary Endothelial Function in Health and Disease

Overview
Journal Drugs
Specialty Pharmacology
Date 1997 Jan 1
PMID 9034752
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The endothelium participates in the control of coronary vascular tone and growth through the release of vasodilating and growth-inhibiting factors such as nitric oxide (NO) and C-type natriuretic peptide (CNP), and vasoconstricting and growth-promoting substances such as endothelin-1 (ET-1). Abnormalities in NO and/or CNP generation or actions have been demonstrated in various cardiovascular pathophysiological states, specifically atherosclerosis, congestive heart failure, hypertension and hypercholesterolaemia. Moreover, an increase in plasma ET-1 levels has also been reported in these disease states. When these observations are considered together, these states may be characterised by an attenuated release or action of NO and/or CNP, together with an augmented release of ET-1. Thus, an imbalance between these opposing factors may contribute to the alteration in vascular tone and the vascular remodelling characteristics of cardiovascular disease. The following article summarises the present knowledge of endothelial control of the coronary circulation and derangements associated with coronary endothelial dysfunction.

Citing Articles

Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential.

Fonseka O, Gare S, Chen X, Zhang J, Alatawi N, Ross C Cells. 2025; 14(5).

PMID: 40072053 PMC: 11899429. DOI: 10.3390/cells14050324.


Role of endothelial dysfunction in heart failure.

Zuchi C, Tritto I, Carluccio E, Mattei C, Cattadori G, Ambrosio G Heart Fail Rev. 2019; 25(1):21-30.

PMID: 31686283 DOI: 10.1007/s10741-019-09881-3.


C-type natriuretic peptide concentrations in the plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage.

Ikeda K, Ikeda T, Onizuka T, Terashi H, Fukuda T Crit Care. 2001; 5(1):37-40.

PMID: 11178224 PMC: 29055. DOI: 10.1186/cc976.


Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.

Goa K, Haria M, Wilde M Drugs. 1997; 53(6):1081-105.

PMID: 9179532 DOI: 10.2165/00003495-199753060-00010.

References
1.
Luscher T, Vanhoutte P . Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986; 8(4):344-8. DOI: 10.1161/01.hyp.8.4.344. View

2.
Cannan C, Burnett Jr J, Brandt R, Lerman A . Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor. Circulation. 1995; 92(11):3312-7. DOI: 10.1161/01.cir.92.11.3312. View

3.
Marsden P, Brenner B . Nitric oxide and endothelins: novel autocrine/paracrine regulators of the circulation. Semin Nephrol. 1991; 11(2):169-85. View

4.
Miller W, Redfield M, Burnett Jr J . Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest. 1989; 83(1):317-20. PMC: 303677. DOI: 10.1172/JCI113876. View

5.
Wei C, Hu S, Miller V, Burnett Jr J . Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells. Biochem Biophys Res Commun. 1994; 205(1):765-71. DOI: 10.1006/bbrc.1994.2731. View